SCHEMBL8855865

SCHEMBL8855865

CCCCCCCCCCC(=O)OCC[N+](C)(C)C

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.74
ADRA2A P08913 1/20 0.67
ADRA1A P35348 1/20 0.67
MAPT P10636 3/20 0.64
BLM P54132 1/20 0.64
DNM1 Q05193 1/20 0.61
ACHE P22303 3/20 0.58
RAD52 P43351 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
PAM P19021 2/20 0.56
FABP3 P05413 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.54
NR5A2 O00482 1/20 0.54
NR5A1 Q13285 1/20 0.54
TSHR P16473 1/20 0.53
PRSS1 P07477 1/20 0.53
PRSS2 P07478 1/20 0.53
PRSS3 P35030 1/20 0.53
NAAA Q02083 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL200767 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL200400 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL198091 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL8385105 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL8383254 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL153530 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL8385120 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL8385098 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL6829812 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM
SCHEMBL8382713 1.00 DGKA (0.74) DGKAADRA2AADRA1AMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034075-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS UNIV MISSISSIPPI (US) 2026-02-05 US disclosed
WO-2024044526-A1 RED BLOOD CELL-HITCHHIKING IONIC LIQUID COATED NANOPARTICLES FOR CROSSING THE BLOOD BRAIN BARRIER UNIVERSITY OF MISSISSIPPI (US) 2024-02-29 WO disclosed
WO-2024030844-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS UNIVERSITY OF MISSISSIPPI (US) 2024-02-08 WO disclosed
US-5614510-A AMMONIUM SALTS PERSTORP AB (SE) 1997-03-25 US disclosed
WO-1993016705-A1 A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE PERSTORP AB (SE) 1993-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034075-A1 CHOLINE CARBOXYLIC ACID BASED IONIC LIQUIDS AS ANTIMICROBIAL AGENTS ELOVL3, L3MBTL3, ELOVL6 DGKA 521/4885ADRA2A 2424/4885ADRA1A 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.